1074 related articles for article (PubMed ID: 16940456)
1. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.
Azziz R; Carmina E; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Futterweit W; Janssen OE; Legro RS; Norman RJ; Taylor AE; Witchel SF;
J Clin Endocrinol Metab; 2006 Nov; 91(11):4237-45. PubMed ID: 16940456
[TBL] [Abstract][Full Text] [Related]
2. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.
Azziz R; Carmina E; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Futterweit W; Janssen OE; Legro RS; Norman RJ; Taylor AE; Witchel SF;
Fertil Steril; 2009 Feb; 91(2):456-88. PubMed ID: 18950759
[TBL] [Abstract][Full Text] [Related]
3. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
Azziz R; Kintziger K; Li R; Laven J; Morin-Papunen L; Merkin SS; Teede H; Yildiz BO
Hum Reprod; 2019 Nov; 34(11):2254-2265. PubMed ID: 31751476
[TBL] [Abstract][Full Text] [Related]
4. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
Azziz R
J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.
March WA; Moore VM; Willson KJ; Phillips DI; Norman RJ; Davies MJ
Hum Reprod; 2010 Feb; 25(2):544-51. PubMed ID: 19910321
[TBL] [Abstract][Full Text] [Related]
6. How polycystic ovary syndrome came into its own.
Azziz R
F S Sci; 2021 Feb; 2(1):2-10. PubMed ID: 35559761
[TBL] [Abstract][Full Text] [Related]
7. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
Wild RA; Carmina E; Diamanti-Kandarakis E; Dokras A; Escobar-Morreale HF; Futterweit W; Lobo R; Norman RJ; Talbott E; Dumesic DA
J Clin Endocrinol Metab; 2010 May; 95(5):2038-49. PubMed ID: 20375205
[TBL] [Abstract][Full Text] [Related]
8. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria.
Franks S
J Clin Endocrinol Metab; 2006 Mar; 91(3):786-9. PubMed ID: 16418209
[TBL] [Abstract][Full Text] [Related]
9. [Current diagnosis of polycystic ovary syndrome: expanding the phenotype but generating new questions].
Merino P; Schulin-Zeuthen C; Codner E
Rev Med Chil; 2009 Aug; 137(8):1071-80. PubMed ID: 19915773
[TBL] [Abstract][Full Text] [Related]
10. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.
Moran LJ; Pasquali R; Teede HJ; Hoeger KM; Norman RJ
Fertil Steril; 2009 Dec; 92(6):1966-82. PubMed ID: 19062007
[TBL] [Abstract][Full Text] [Related]
11. The spectrum of androgen excess disorders.
Carmina E
Fertil Steril; 2006 Jun; 85(6):1582-5. PubMed ID: 16759919
[TBL] [Abstract][Full Text] [Related]
12. Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society.
Salley KE; Wickham EP; Cheang KI; Essah PA; Karjane NW; Nestler JE
J Clin Endocrinol Metab; 2007 Dec; 92(12):4546-56. PubMed ID: 18056778
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
[TBL] [Abstract][Full Text] [Related]
14. Evidence-based approach for the use of ultrasound in the management of polycystic ovary syndrome.
Nardo LG; Gelbaya TA
Minerva Ginecol; 2008 Feb; 60(1):83-9. PubMed ID: 18277355
[TBL] [Abstract][Full Text] [Related]
15. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
Fertil Steril; 2004 Jan; 81(1):19-25. PubMed ID: 14711538
[TBL] [Abstract][Full Text] [Related]
16. Do Different Diagnostic Criteria Impact Polycystic Ovary Syndrome Diagnosis for Adolescents?
Akgül S; Düzçeker Y; Kanbur N; Derman O
J Pediatr Adolesc Gynecol; 2018 Jun; 31(3):258-262. PubMed ID: 29233731
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines.
Carmina E
Minerva Ginecol; 2004 Feb; 56(1):1-6. PubMed ID: 14973405
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of polycystic ovary syndrome.
Trivax B; Azziz R
Clin Obstet Gynecol; 2007 Mar; 50(1):168-77. PubMed ID: 17304034
[TBL] [Abstract][Full Text] [Related]
19. The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research.
Barth JH; Yasmin E; Balen AH
Clin Endocrinol (Oxf); 2007 Dec; 67(6):811-5. PubMed ID: 17760885
[TBL] [Abstract][Full Text] [Related]
20. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
Pasquali R; Patton L; Pocognoli P; Cognigni GE; Gambineri A
J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
